Qube Research & Technologies LTD Novo Nordisk A S Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Novo Nordisk A S stock. As of the latest transaction made, Qube Research & Technologies LTD holds 662,243 shares of NVO stock, worth $57.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
662,243
Previous 726,642 8.86%
Holding current value
$57.9 Million
Previous $104 Million 23.98%
% of portfolio
0.12%
Previous 0.17%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$119.07 - $145.42 $7.67 Million - $9.36 Million
-64,399 Reduced 8.86%
662,243 $78.9 Million
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $798,964 - $956,531
6,511 Added 0.9%
726,642 $104 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $37 Million - $49.3 Million
362,361 Added 101.28%
720,131 $92.5 Million
Q4 2023

Feb 13, 2024
SELL
$87.78 - $105.45 $20.8 Million - $24.9 Million
-236,554 Reduced 39.8%
357,770 $37 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $40.1 Million - $88.1 Million
441,288 Added 288.36%
594,324 $54 Million
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $23.9 Million - $26.4 Million
153,036 New
153,036 $24.8 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $5.52 Million - $6.77 Million
-57,898 Reduced 53.73%
49,858 $4.97 Million
Q2 2022

Aug 15, 2022
BUY
$103.24 - $121.81 $11.1 Million - $13.1 Million
107,756 New
107,756 $12 Million
Q1 2022

May 09, 2022
SELL
$93.1 - $112.54 $237,777 - $287,427
-2,554 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$95.88 - $117.08 $5.65 Million - $6.9 Million
-58,921 Reduced 95.85%
2,554 $286,000
Q3 2021

Nov 12, 2021
BUY
$84.42 - $106.62 $5.19 Million - $6.55 Million
61,475 New
61,475 $5.9 Million
Q2 2021

Aug 13, 2021
SELL
$67.66 - $84.76 $2.46 Million - $3.08 Million
-36,359 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$67.06 - $75.82 $913,893 - $1.03 Million
-13,628 Reduced 27.26%
36,359 $2.45 Million
Q4 2020

Feb 16, 2021
SELL
$63.89 - $73.8 $942,696 - $1.09 Million
-14,755 Reduced 22.79%
49,987 $3.49 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $1.48 Million - $1.63 Million
-23,180 Reduced 26.36%
64,742 $4.5 Million
Q2 2020

Aug 14, 2020
BUY
$58.54 - $67.94 $5.15 Million - $5.97 Million
87,922 New
87,922 $5.76 Million
Q1 2020

May 15, 2020
SELL
$49.46 - $64.78 $611,177 - $800,486
-12,357 Closed
0 $0
Q4 2019

Feb 13, 2020
SELL
$49.86 - $58.26 $193,706 - $226,340
-3,885 Reduced 23.92%
12,357 $715,000
Q3 2019

Nov 13, 2019
BUY
$47.54 - $53.43 $772,144 - $867,810
16,242 New
16,242 $840,000
Q2 2018

Aug 14, 2018
SELL
$44.29 - $50.42 $2,170 - $2,470
-49 Closed
0 $0
Q1 2018

May 14, 2018
BUY
$48.49 - $58.14 $2,376 - $2,848
49 New
49 $2,000

Others Institutions Holding NVO

# of Institutions
1,957
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email